1064. Treatment Success in Reducing Recurrent <i>Clostridioides difficile</i> Infection with Investigational Live Biotherapeutic RBX2660 Is Associated with Microbiota Restoration: Consistent Evidence from a Phase 3 Clinical Trial
Open forum infectious diseases